Literature DB >> 6238095

Lysine residues, but not carbohydrates, are required for the regulatory function of H on the amplification C3 convertase of complement.

M H Jouvin, M D Kazatchkine, A Cahour, N Bernard.   

Abstract

Lysine epsilon-amino groups of human factor H were selectively converted to guanidino groups by treatment with 0.1 M O-methylisourea at pH 10.4. Guanidination resulted in a dose-dependent decrease in the capacity of the regulatory protein to accelerate decay dissociation of P-stabilized amplification C3 convertase sites, to serve as a co-factor for cleavage of cell-bound C3b by I, and to compete for binding of 125I-untreated H to C3b. Modification of approximately 75% lysine epsilon-amino groups suppressed 97% of H functional activity. Biochemical analysis of native H demonstrated a total carbohydrate content of 18.5% (w/w) and the presence in the molecule of 11 biantennary oligosaccharidic chains of the N-acetyl-lactosaminic type. Total desialation of H by using Clostridium perfringens neuraminidase, and total deglycosylation of desialated H by using beta-endo-N-acetylglucosaminidase resulted in a 1.5- to 2-fold increase in H activity on a weight basis. Deglycosylation did not alter the capacity of H to discriminate between activating and nonactivating surfaces of the alternative pathway. Thus, lysine residues are important determinants of the binding capacity of H for cell-bound C3b, whereas the carbohydrate portion of the molecule is not required for the regulatory function of the protein on the amplification C3 convertase.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6238095

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Suboptimal C3b/C3bi deposition and defective yeast opsonization. I. Evidence for the absence of essential co-factor activity.

Authors:  M W Turner; N D Seymour; M D Kazatchkine; J F Mowbray
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

2.  The principal site of glycation of human complement factor B.

Authors:  M A Niemann; A S Bhown; E J Miller
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

3.  Sheep Erythrocyte Preparation for Hemolytic Tests Exploring Complement Functional Activities.

Authors:  Melchior Chabannes; Pauline Bordereau; Paula Vieira Martins; Marie-Agnès Dragon-Durey
Journal:  Methods Mol Biol       Date:  2021

4.  Prevalence of the 1.8 kb complement factor H mRNA in human lung.

Authors:  M J Demares; C Davrinche
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

Review 5.  Complement factor H: using atomic resolution structure to illuminate disease mechanisms.

Authors:  Paul N Barlow; Gregory S Hageman; Susan M Lea
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 6.  Translational mini-review series on complement factor H: structural and functional correlations for factor H.

Authors:  C Q Schmidt; A P Herbert; H G Hocking; D Uhrín; P N Barlow
Journal:  Clin Exp Immunol       Date:  2008-01       Impact factor: 4.330

7.  gp 58/68, a parasite component that contributes to the escape of the trypomastigote form of T. cruzi from damage by the human alternative complement pathway.

Authors:  E Fischer; M A Ouaissi; P Velge; J Cornette; M D Kazatchkine
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

8.  Murine protein H is comprised of 20 repeating units, 61 amino acids in length.

Authors:  T Kristensen; B F Tack
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

9.  Production of biologically active complement factor H in therapeutically useful quantities.

Authors:  Christoph Q Schmidt; Fern C Slingsby; Anna Richards; Paul N Barlow
Journal:  Protein Expr Purif       Date:  2010-12-10       Impact factor: 1.650

10.  Murine Factor H Co-Produced in Yeast With Protein Disulfide Isomerase Ameliorated C3 Dysregulation in Factor H-Deficient Mice.

Authors:  Heather Kerr; Andrew P Herbert; Elisavet Makou; Dariusz Abramczyk; Talat H Malik; Hannah Lomax-Browne; Yi Yang; Isabel Y Pappworth; Harriet Denton; Anna Richards; Kevin J Marchbank; Matthew C Pickering; Paul N Barlow
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.